Skip to content
CIFAR header logo
fr
menu_mobile_logo_alt
  • Our Impact
    • Why CIFAR?
    • Impact Clusters
    • News
    • CIFAR Strategy
    • Nurturing a Resilient Earth
    • AI Impact
    • Donor Impact
    • CIFAR 40
  • Events
    • Public Events
    • Invitation-only Meetings
  • Programs
    • Research Programs
    • Pan-Canadian AI Strategy
    • Next Generation Initiatives
  • People
    • Fellows & Advisors
    • CIFAR Azrieli Global Scholars
    • Canada CIFAR AI Chairs
    • AI Strategy Leadership
    • Solution Network Members
    • Leadership
    • Staff Directory
  • Support Us
  • About
    • Our Story
    • Awards
    • Partnerships
    • Publications & Reports
    • Careers
    • Equity, Diversity & Inclusion
    • Statement on Institutional Neutrality
    • Research Security
  • fr
  • Home
  • Bio

Follow Us

Don Sheppard

Don Sheppard

Appointment

Fellow

Fungal Kingdom: Threats & Opportunities

Connect

Website

About

Don Sheppard is an infectious diseases physician and medical microbiologist who he leads the Medical Mycology laboratory and practices clinical infectious diseases at the McGill University Health Centre.

He is primarily interested in human fungal disease, particularly invasive aspergillosis in the immunocompromised host. Sheppard’s research interests focus on elucidating how the fungal pathogen Aspergillus fumigatus causes human disease and developing new therapeutics for these infections. His research group has discovered the molecular mechanism by which Aspergillus forms biofilms and is pursuing antifungal therapies that interfere with this process.

Awards

  • Fellow, American Academy of Microbiology, 2018
  • Fellow, American Society of Clinical Investigation, 2018
  • Fonds du Québec Recherche Santé: Research Chair, 2017
  • Fellow, Canadian Academy of Health Sciences, 2017
  • Career Award in the Biomedical Sciences, Burroughs-Wellcome Fund, 2002

Relevant Publications

  • Snarr BD, Baker P, Bamford NC, Sato Y, Liu H, Lehoux M, Gravelat FN, Ostapska H, Baistrocchi SR, Cerone RP, Filler EE, Parsek MR, Filler SG, Howell PL, Sheppard DC. Microbial glycoside hydrolases as antibiofilm agents with cross-kingdom activity. Proc Natl Acad Sci U S A. 2017;114(27):7124-9. doi: 10.1073/pnas.1702798114. PubMed PMID: 28634301.

  • Lee MJ, Geller A, Bamford NC, Liu H, Gravelat FN, Snarr BD, Le Mauff F, Chabot J, Ralph B, Ostapska H, Lehoux M, Cerone RP, Baptista SD, Vinogradov E, Stajich JE, Filler SG, Howell PL, Sheppard DC*. (2016) Deacetylation of fungal exopolysaccharide mediates adhesion and biofilm formation. mBio 7(2):e00252-16. PMID: 27048799

  • Lee MJ, Liu H, Barker BM, Snarr BD, Gravelat FN, Al Abdallah Q, Gavino C, Baistrocchi SR, Ostapska H, Xiao T, Ralph B, Solis NV, Lehoux M, Baptista SD, Thammahong A, Cerone RP, Kaminskyj SG, Guiot MC, Latge JP, Fontaine T, Vinh DC, Filler SG, Sheppard DC. The Fungal Exopolysaccharide Galactosaminogalactan Mediates Virulence by Enhancing Resistance to Neutrophil Extracellular Traps. PLoS Pathog. 2015;11(10):e1005187. doi: 10.1371/journal.ppat.1005187. PubMed PMID: 26492565; PMCID: PMC4619649.

  • Urb M, Snarr BD, Wojewodka G, Lehoux M, Lee MJ, Ralph B, Divangahi M, King IL, McGovern TK, Martin JG, Fraser R, Radzioch D, Sheppard DC. Evolution of the Immune Response to Chronic Airway Colonization with Aspergillus fumigatus Hyphae. Infect Immun. 2015;83(9):3590-600. doi: 10.1128/IAI.00359-15. PubMed PMID: 26123803; PMCID: PMC4534667.

  • Gravelat FN, Beauvais A, Liu H, Lee MJ, Snarr BD, Chen D, Xu W, Kravtsov I, Hoareau CM, Vanier G, Urb M, Campoli P, Al Abdallah Q, Lehoux M, Chabot JC, Ouimet MC, Baptista SD, Fritz JH, Nierman WC, Latge JP, Mitchell AP, Filler SG, Fontaine T, Sheppard DC. Aspergillus galactosaminogalactan mediates adherence to host constituents and conceals hyphal beta-glucan from the immune system. PLoS Pathog. 2013;9(8):e1003575. doi: 10.1371/journal.ppat.1003575. PubMed PMID: 23990787; PMCID: PMC3749958.

Institution

McGill University

Department

Microbiology and Immunology; Medicine;Research Institute of the McGill University Health Centre

Education

  • MD, University of Toronto
  • Fellowship (Infectious Disease), UC San Francisco
  • Fellowship (Medical Microbiology), McGill University

Country

Canada

Support Us

The Canadian Institute for Advanced Research (CIFAR) is a globally influential research organization proudly based in Canada. We mobilize the world’s most brilliant people across disciplines and at all career stages to advance transformative knowledge and solve humanity’s biggest problems, together. We are supported by the governments of Canada, Alberta and Québec, as well as Canadian and international foundations, individuals, corporations and partner organizations.

Donate Now
CIFAR footer logo

MaRS Centre, West Tower
661 University Ave., Suite 505
Toronto, ON M5G 1M1 Canada

Contact Us
Media
Careers
Accessibility Policies
Supporters
Financial Reports
Subscribe

  • © Copyright 2025 CIFAR. All Rights Reserved.
  • Charitable Registration Number: 11921 9251 RR0001
  • Terms of Use
  • Privacy
  • Sitemap

Subscribe

Stay up to date on news & ideas from CIFAR.

Fields marked with an * are required

Je préfère m’inscrire en français (cliquez ici).


Subscribe to our CIFAR newsletters: *

You can unsubscribe from these communications at any time. View our privacy policy.


As a subscriber you will also receive a digital copy of REACH, our annual magazine which highlights our researchers and their breakthroughs with long-form features, interviews and illustrations.


Please provide additional information if you would like to receive a print edition of REACH.


This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.
Accept Learn more

Notifications